Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.

Du SW, Jacobs HM, Arkatkar T, Rawlings DJ, Jackson SW.

J Immunol. 2018 Dec 1;201(11):3258-3268. doi: 10.4049/jimmunol.1800393. Epub 2018 Oct 29.

PMID:
30373855
2.

Generation of functional murine CD11c+ age-associated B cells in the absence of B cell T-bet expression.

Du SW, Arkatkar T, Jacobs HM, Rawlings DJ, Jackson SW.

Eur J Immunol. 2019 Jan;49(1):170-178. doi: 10.1002/eji.201847641. Epub 2018 Nov 5.

PMID:
30353919
3.

TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.

Arkatkar T, Jacobs HM, Du SW, Li QZ, Hudkins KL, Alpers CE, Rawlings DJ, Jackson SW.

Kidney Int. 2018 Oct;94(4):728-740. doi: 10.1016/j.kint.2018.03.012. Epub 2018 Jun 12.

PMID:
29907458
4.

Nrf2a modulates the embryonic antioxidant response to perfluorooctanesulfonic acid (PFOS) in the zebrafish, Danio rerio.

Sant KE, Sinno PP, Jacobs HM, Timme-Laragy AR.

Aquat Toxicol. 2018 May;198:92-102. doi: 10.1016/j.aquatox.2018.02.010. Epub 2018 Feb 20.

PMID:
29524743
5.

Embryonic exposure to Mono(2-ethylhexyl) phthalate (MEHP) disrupts pancreatic organogenesis in zebrafish (Danio rerio).

Jacobs HM, Sant KE, Basnet A, Williams LM, Moss JB, Timme-Laragy AR.

Chemosphere. 2018 Mar;195:498-507. doi: 10.1016/j.chemosphere.2017.12.094. Epub 2017 Dec 15.

6.

B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity.

Arkatkar T, Du SW, Jacobs HM, Dam EM, Hou B, Buckner JH, Rawlings DJ, Jackson SW.

J Exp Med. 2017 Nov 6;214(11):3207-3217. doi: 10.1084/jem.20170580. Epub 2017 Sep 12.

7.

Assessment of Toxicological Perturbations and Variants of Pancreatic Islet Development in the Zebrafish Model.

Sant KE, Jacobs HM, Xu J, Borofski KA, Moss LG, Moss JB, Timme-Laragy AR.

Toxics. 2016 Sep;4(3). pii: 20. doi: 10.3390/toxics4030020. Epub 2016 Sep 2.

8.

Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells.

Hale M, Lee B, Honaker Y, Leung WH, Grier AE, Jacobs HM, Sommer K, Sahni J, Jackson SW, Scharenberg AM, Astrakhan A, Rawlings DJ.

Mol Ther Methods Clin Dev. 2017 Jan 10;4:192-203. doi: 10.1016/j.omtm.2016.12.008. eCollection 2017 Mar 17.

9.

Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation.

Jackson SW, Scharping NE, Jacobs HM, Wang S, Chait A, Rawlings DJ.

J Immunol. 2016 Dec 15;197(12):4529-4534. Epub 2016 Nov 11.

10.

Embryonic exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio.

Sant KE, Jacobs HM, Borofski KA, Moss JB, Timme-Laragy AR.

Environ Pollut. 2017 Jan;220(Pt B):807-817. doi: 10.1016/j.envpol.2016.10.057. Epub 2016 Oct 31.

11.

B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6.

Jackson SW, Jacobs HM, Arkatkar T, Dam EM, Scharping NE, Kolhatkar NS, Hou B, Buckner JH, Rawlings DJ.

J Exp Med. 2016 May 2;213(5):733-50. doi: 10.1084/jem.20151724. Epub 2016 Apr 11.

12.

Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells.

Jacobs HM, Thouvenel CD, Leach S, Arkatkar T, Metzler G, Scharping NE, Kolhatkar NS, Rawlings DJ, Jackson SW.

J Immunol. 2016 May 1;196(9):3525-31. doi: 10.4049/jimmunol.1600017. Epub 2016 Mar 28.

13.

Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome.

Kolhatkar NS, Brahmandam A, Thouvenel CD, Becker-Herman S, Jacobs HM, Schwartz MA, Allenspach EJ, Khim S, Panigrahi AK, Luning Prak ET, Thrasher AJ, Notarangelo LD, Candotti F, Torgerson TR, Sanz I, Rawlings DJ.

J Exp Med. 2015 Sep 21;212(10):1663-77. doi: 10.1084/jem.20150585. Epub 2015 Sep 14.

14.

B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome.

Kolhatkar NS, Scharping NE, Sullivan JM, Jacobs HM, Schwartz MA, Khim S, Notarangelo LD, Thrasher AJ, Rawlings DJ, Jackson SW.

Eur J Immunol. 2015 Oct;45(10):2773-9. doi: 10.1002/eji.201545644. Epub 2015 Aug 31. Erratum in: Eur J Immunol. 2016 Mar;46(3):782.

15.

Molecular and cellular effects of NEDD8-activating enzyme inhibition in myeloma.

McMillin DW, Jacobs HM, Delmore JE, Buon L, Hunter ZR, Monrose V, Yu J, Smith PG, Richardson PG, Anderson KC, Treon SP, Kung AL, Mitsiades CS.

Mol Cancer Ther. 2012 Apr;11(4):942-51. doi: 10.1158/1535-7163.MCT-11-0563. Epub 2012 Jan 12.

16.

BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS.

Cell. 2011 Sep 16;146(6):904-17. doi: 10.1016/j.cell.2011.08.017. Epub 2011 Sep 1.

17.

Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.

McMillin DW, Delmore J, Negri J, Buon L, Jacobs HM, Laubach J, Jakubikova J, Ooi M, Hayden P, Schlossman R, Munshi NC, Lengauer C, Richardson PG, Anderson KC, Mitsiades CS.

Br J Haematol. 2011 Feb;152(4):420-32. doi: 10.1111/j.1365-2141.2010.08427.x. Epub 2011 Jan 11.

18.

Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.

Höppener JW, Jacobs HM, Wierup N, Sotthewes G, Sprong M, de Vos P, Berger R, Sundler F, Ahrén B.

Exp Diabetes Res. 2008;2008:697035. doi: 10.1155/2008/697035.

19.

Fibrinolytic markers and vasodilatory capacity following acute exercise among men of differing training status.

Baynard T, Jacobs HM, Kessler CM, Kanaley JA, Fernhall B.

Eur J Appl Physiol. 2007 Nov;101(5):595-602. Epub 2007 Aug 4.

PMID:
17676334
20.

Changes in blood coagulation markers associated with uterine artery embolization for leiomyomata.

Nikolic B, Kessler CM, Jacobs HM, Abbara S, Ammann AM, Neeman Z, McCullough MF, Martinez H, Spies JB.

J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1147-53.

PMID:
14514806
21.

Transient ischaemic attacks: desired diagnosis and management by Polish primary care physicians.

Tomasik T, Windak A, Margas G, de Melker RA, Jacobs HM.

Fam Pract. 2003 Aug;20(4):464-8.

PMID:
12876122
22.

Progesterone receptor, bc1-2 and bax expression in meningiomas.

Verheijen FM, Donker GH, Viera CS, Sprong M, Jacobs HM, Blaauw G, Thijssen JH, Blankenstein MA.

J Neurooncol. 2002 Jan;56(1):35-41.

PMID:
11949825
23.

Progesterone receptor isoform expression in human meningiomas.

Verheijen FM, Sprong M, Jacobs HM, Donker GH, Amelink GJ, Thijssen JH, Blankenstein MA.

Eur J Cancer. 2001 Aug;37(12):1488-95.

PMID:
11506955
24.

The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas.

Jacobs HM, van Spriel AB, Koehorst SG, Thijssen JH, Blaauw G, Blankenstein MA.

J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):167-72.

PMID:
10704905
25.

Essential role of LAT in T cell development.

Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg A, Tsay HC, Jacobs HM, Kessler CM, Long EO, Love PE, Samelson LE.

Immunity. 1999 Mar;10(3):323-32.

26.

Assessment of the quality of life of patients with advanced and end-stage cancer or serious infections with a symptom-based or an impact-based instrument.

Witteveen PO, Jacobs HM, van Groenestijn MA, Lodder AC, van Boxtel AH, Nieuwland M, Post MW, Touw-Otten FW, Blijham GH.

Support Care Cancer. 1999 Mar;7(2):64-70.

PMID:
10089084
27.

Changes in health-related quality of life after carotid endarterectomy.

Vriens EM, Post MW, Jacobs HM, van Huffelen AC, Eikelboom BC.

Eur J Vasc Endovasc Surg. 1998 Nov;16(5):395-400.

29.

Residual health status after Guillain-Barré syndrome.

Bernsen RA, Jacobs HM, de Jager AE, van der Meché FG.

J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):637-40.

30.
31.

The evaluation of changes in functional health status in patients with abdominal complaints.

Jacobs HM, Touw-Otten FW, de Melker RA.

J Clin Epidemiol. 1996 Feb;49(2):163-71.

PMID:
8606317
32.

Oestrogen receptor independent expression of progestin receptors in human meningioma--a review.

Blankenstein MA, Koehorst SG, van der Kallen CJ, Jacobs HM, van Spriel AB, Donker GH, van't Verlaat JW, Blaauw G, Thijssen JH.

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):361-5.

PMID:
7626481
33.

Monitoring the anticoagulant effects of a low molecular weight heparin preparation. Correlation of assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosis.

Kessler CM, Esparraguera IM, Jacobs HM, Druy E, Fortune WP, Holloway DS, Giordano J, Davidson BL.

Am J Clin Pathol. 1995 May;103(5):642-8.

PMID:
7741113
34.

Quality of life after stroke. Impact of stroke type and lesion location.

de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK.

Stroke. 1995 Mar;26(3):402-8.

PMID:
7886714
35.
36.

Estrogen receptor variants mRNA in human meningiomas.

Koehorst SG, Jacobs HM, Thijssen JH, Blankenstein MA.

Ann N Y Acad Sci. 1993 Jun 11;684:222-3. No abstract available.

PMID:
8317837
37.

Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.

Koehorst SG, Jacobs HM, Thijssen JH, Blankenstein MA.

J Steroid Biochem Mol Biol. 1993 Apr;45(4):227-33.

PMID:
8499331
38.

Aberrant oestrogen receptor species in human meningioma tissue.

Koehorst SG, Jacobs HM, Tilanus MG, Bouwens AG, Thijssen JH, Blankenstein MA.

J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):57-61.

PMID:
1525066
39.

Measuring impact of sickness in patients with nonspecific abdominal complaints in a Dutch family practice setting.

Jacobs HM, Luttik A, Touw-Otten FW, Kastein M, de Melker RA.

Med Care. 1992 Mar;30(3):244-51.

PMID:
1538612
40.

[The sickness impact profile; results of an evaluation study of the Dutch version].

Jacobs HM, Luttik A, Touw-Otten FW, de Melker RA.

Ned Tijdschr Geneeskd. 1990 Oct 6;134(40):1950-4. Dutch.

PMID:
2234151
41.

The association between peer consultations and three aspects of clinical competence.

Kuyvenhoven MM, Pieters HM, Jacobs HM, Touw-Otten FW, Spreeuwenberg C.

Fam Pract. 1990 Sep;7(3):163-7.

PMID:
2245884
42.

[Value of the sickness impact profile as outcome measure].

de Melker RA, Touw-Otten F, Jacobs HM, Luttik A.

Ned Tijdschr Geneeskd. 1990 May 12;134(19):946-8. Dutch. No abstract available.

PMID:
2348880
43.

Do peer consultations improve quality of care in general practice?

Kuyvenhoven MM, Pieters HM, Jacobs HM, Touw-Otten FW, Spreeuwenberg C.

Qual Assur Health Care. 1990;2(2):171-9.

PMID:
2103882
44.

Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the label.

Kurantsin-Mills J, Jacobs HM, Siegel R, Cassidy MM, Lessin LS.

Int J Rad Appl Instrum B. 1989;16(8):821-7.

PMID:
2516078
45.

Flow dynamics of human sickle erythrocytes in the mesenteric microcirculation of the exchange-transfused rat.

Kurantsin-Mills J, Jacobs HM, Klug PP, Lessin LS.

Microvasc Res. 1987 Sep;34(2):152-67.

PMID:
3670112
46.

Assessment of the hydration state of sickle cells by phthalate ester density distribution.

Kurantsin-Mills J, Jacobs HM, Lessin LS.

J Lab Clin Med. 1987 Apr;109(4):486-94.

PMID:
3819582
47.
48.

Written simulation of patient-doctor encounters. 2. Assessment of the performance of general practitioners.

Jacobs HM, Kuyvenhoven MM, Touw-Otten FW, van Es JC.

Fam Pract. 1984 Mar;1(1):20-4.

PMID:
6530058
49.
50.

Supplemental Content

Loading ...
Support Center